Skip to main content
. Author manuscript; available in PMC: 2009 Sep 17.
Published in final edited form as: Psychol Med. 2007 Nov 30;38(3):365–374. doi: 10.1017/S0033291707002012

Table 2.

Time-lagged associations of baseline MDE predicting the persistence of GAD and of baseline GAD predicting the persistence of MDE by cohort in the NCS-2 panel sample

Cohorts (Age at baseline)

Total 15–24 25–39 40–54
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)




I. Baseline MDE predicting the persistence of GAD
   MDE 1.2    (0.9–1.7) 1.2    (0.5–2.6) 1.1    (0.7–1.8) 1.3    (0.8–2.1)
   AOO of GAD 0.9*    (0.7–1.0) 0.9    (0.4–1.9) 0.8    (0.7–1.0) 0.8*    (0.6–1.0)
     (n)2 (531) (74) (258) (199)
II. Baseline GAD predicting the persistence of MDE
   GAD 1.8*    (1.4–2.4) 2.6*    (1.4–4.6) 1.5*    (1.1–2.2) 1.9*    (1.3–2.7)
   AOO of MDE 0.8*    (0.7–0.9) 0.4*    (0.2–0.8) 0.7*    (0.6–0.9) 0.9    (0.8–1.1)
     (n)2 (1442) (313) (698) (431)
*

Significant at the .05 level, two-sided test

1

Based on a discrete-time survival model with person-year as the unit of analysis, controlling for cohort (age at interview), gender, race-ethnicity, and person-year.

2

Unweighted sample sizes

HHS Vulnerability Disclosure